"MELAS Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A mitochondrial disorder characterized by focal or generalized seizures, episodes of transient or persistent neurologic dysfunction resembling strokes, and ragged-red fibers on muscle biopsy. Affected individuals tend to be normal at birth through early childhood, then experience growth failure, episodic vomiting, and recurrent cerebral insults resulting in visual loss and hemiparesis. The cortical lesions tend to occur in the parietal and occipital lobes and are not associated with vascular occlusion. VASCULAR HEADACHE is frequently associated and the disorder tends to be familial. (From Joynt, Clinical Neurology, 1992, Ch56, p117)
Descriptor ID |
D017241
|
MeSH Number(s) |
C05.651.460.620.520 C10.228.140.163.100.535 C10.228.140.300.275.500 C10.668.491.500.500.500 C14.907.253.329.500 C16.320.565.189.535 C18.452.132.100.535 C18.452.648.189.535 C18.452.660.560.620.520
|
Concept/Terms |
MELAS Syndrome- MELAS Syndrome
- Syndrome, MELAS
- Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes
- Mitochondrial Myopathy, Lactic Acidosis, Stroke-Like Episode
- Myopathy, Mitochondrial-Encephalopathy-Lactic Acidosis-Stroke
- MELAS
- Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, And Stroke-Like Episodes
|
Below are MeSH descriptors whose meaning is more general than "MELAS Syndrome".
- Diseases [C]
- Musculoskeletal Diseases [C05]
- Muscular Diseases [C05.651]
- Mitochondrial Myopathies [C05.651.460]
- Mitochondrial Encephalomyopathies [C05.651.460.620]
- MELAS Syndrome [C05.651.460.620.520]
- Nervous System Diseases [C10]
- Central Nervous System Diseases [C10.228]
- Brain Diseases [C10.228.140]
- Brain Diseases, Metabolic [C10.228.140.163]
- Brain Diseases, Metabolic, Inborn [C10.228.140.163.100]
- MELAS Syndrome [C10.228.140.163.100.535]
- Cerebrovascular Disorders [C10.228.140.300]
- Cerebral Small Vessel Diseases [C10.228.140.300.275]
- MELAS Syndrome [C10.228.140.300.275.500]
- Neuromuscular Diseases [C10.668]
- Muscular Diseases [C10.668.491]
- Mitochondrial Myopathies [C10.668.491.500]
- Mitochondrial Encephalomyopathies [C10.668.491.500.500]
- MELAS Syndrome [C10.668.491.500.500.500]
- Cardiovascular Diseases [C14]
- Vascular Diseases [C14.907]
- Cerebrovascular Disorders [C14.907.253]
- Cerebral Small Vessel Diseases [C14.907.253.329]
- MELAS Syndrome [C14.907.253.329.500]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
- Metabolism, Inborn Errors [C16.320.565]
- Brain Diseases, Metabolic, Inborn [C16.320.565.189]
- MELAS Syndrome [C16.320.565.189.535]
- Nutritional and Metabolic Diseases [C18]
- Metabolic Diseases [C18.452]
- Brain Diseases, Metabolic [C18.452.132]
- Brain Diseases, Metabolic, Inborn [C18.452.132.100]
- MELAS Syndrome [C18.452.132.100.535]
- Metabolism, Inborn Errors [C18.452.648]
- Brain Diseases, Metabolic, Inborn [C18.452.648.189]
- MELAS Syndrome [C18.452.648.189.535]
- Mitochondrial Diseases [C18.452.660]
- Mitochondrial Myopathies [C18.452.660.560]
- Mitochondrial Encephalomyopathies [C18.452.660.560.620]
- MELAS Syndrome [C18.452.660.560.620.520]
Below are MeSH descriptors whose meaning is more specific than "MELAS Syndrome".
This graph shows the total number of publications written about "MELAS Syndrome" by people in this website by year, and whether "MELAS Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2006 | 1 | 0 | 1 |
2007 | 1 | 0 | 1 |
2009 | 0 | 1 | 1 |
2012 | 2 | 0 | 2 |
2014 | 2 | 0 | 2 |
2015 | 1 | 0 | 1 |
2016 | 2 | 0 | 2 |
2017 | 2 | 0 | 2 |
2022 | 1 | 0 | 1 |
2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "MELAS Syndrome" by people in Profiles.
-
Heteroplasmic pathogenic m.12315G>A variant in MT-TL2 presenting with MELAS syndrome and depletion of nitric oxide donors. Am J Med Genet A. 2024 03; 194(3):e63461.
-
First Case of MELAS Syndrome Presenting with Local Brain Edema Requiring Decompressive Craniectomy. Turk Neurosurg. 2022; 32(1):155-159.
-
Apomorphine rescues reactive oxygen species-induced apoptosis of fibroblasts with mitochondrial disease. Mitochondrion. 2019 11; 49:111-120.
-
The nuclear background influences the penetrance of the near-homoplasmic m.1630 A?>?G MELAS variant in a symptomatic proband and asymptomatic mother. Mol Genet Metab. 2019 04; 126(4):429-438.
-
The utility of arginine-citrulline stable isotope tracer infusion technique in the assessment of nitric oxide production in MELAS syndrome. Int J Cardiol. 2018 03 01; 254:282.
-
Assessment of Nitric Oxide Production in Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes Syndrome with the Use of a Stable Isotope Tracer Infusion Technique. J Nutr. 2017 07; 147(7):1251-1257.
-
Teaching NeuroImages: Medullary lesions causing dysphagia in Leigh/MELAS overlap syndrome. Neurology. 2016 07 12; 87(2):e18-9.
-
Recommendations for the Management of Strokelike Episodes in Patients With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Strokelike Episodes. JAMA Neurol. 2016 May 01; 73(5):591-4.
-
Impaired nitric oxide production in children with MELAS syndrome and the effect of arginine and citrulline supplementation. Mol Genet Metab. 2016 Apr; 117(4):407-12.
-
MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options. Mol Genet Metab. 2015 Sep-Oct; 116(1-2):4-12.